Literature DB >> 29632145

Inflammatory Macrophage Expansion in Pulmonary Hypertension Depends upon Mobilization of Blood-Borne Monocytes.

Jonathan Florentin1, Emilie Coppin1, Sathish Babu Vasamsetti1, Jingsi Zhao1, Yi-Yin Tai1, Ying Tang1, Yingze Zhang2, Annie Watson1, John Sembrat1,3, Mauricio Rojas1,3, Sara O Vargas4, Stephen Y Chan5, Partha Dutta5,6.   

Abstract

Pulmonary inflammation, which is characterized by the presence of perivascular macrophages, has been proposed as a key pathogenic driver of pulmonary hypertension (PH), a vascular disease with increasing global significance. However, the mechanisms of expansion of lung macrophages and the role of blood-borne monocytes in PH are poorly understood. Using multicolor flow cytometric analysis of blood in mouse and rat models of PH and patients with PH, an increase in blood monocytes was observed. In parallel, lung tissue displayed increased chemokine transcript expression, including those responsible for monocyte recruitment, such as Ccl2 and Cx3cl1, accompanied by an expansion of interstitial lung macrophages. These data indicate that blood monocytes are recruited to lung perivascular spaces and differentiate into inflammatory macrophages. Correspondingly, parabiosis between congenically different hypoxic mice demonstrated that most interstitial macrophages originated from blood monocytes. To define the actions of these cells in PH in vivo, we reduced blood monocyte numbers via genetic deficiency of cx3cr1 or ccr2 in chronically hypoxic male mice and by pharmacologic inhibition of Cx3cl1 in monocrotaline-exposed rats. Both models exhibited decreased inflammatory blood monocytes, as well as interstitial macrophages, leading to a substantial decrease in arteriolar remodeling but with a less robust hemodynamic effect. This study defines a direct mechanism by which interstitial macrophages expand in PH. It also demonstrates a pathway for pulmonary vascular remodeling in PH that depends upon interstitial macrophage-dependent inflammation yet is dissociated, at least in part, from hemodynamic consequences, thus offering guidance on future anti-inflammatory therapeutic strategies in this disease.
Copyright © 2018 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29632145      PMCID: PMC5940510          DOI: 10.4049/jimmunol.1701287

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  78 in total

Review 1.  Functional heterogeneity in liver and lung macrophages.

Authors:  D L Laskin; B Weinberger; J D Laskin
Journal:  J Leukoc Biol       Date:  2001-08       Impact factor: 4.962

2.  Hypoxia-induced pulmonary vascular remodeling requires recruitment of circulating mesenchymal precursors of a monocyte/macrophage lineage.

Authors:  Maria G Frid; Jacqueline A Brunetti; Danielle L Burke; Todd C Carpenter; Neil J Davie; John T Reeves; Mark T Roedersheimer; Nico van Rooijen; Kurt R Stenmark
Journal:  Am J Pathol       Date:  2006-02       Impact factor: 4.307

3.  Fate mapping reveals origins and dynamics of monocytes and tissue macrophages under homeostasis.

Authors:  Simon Yona; Ki-Wook Kim; Yochai Wolf; Alexander Mildner; Diana Varol; Michal Breker; Dalit Strauss-Ayali; Sergey Viukov; Martin Guilliams; Alexander Misharin; David A Hume; Harris Perlman; Bernard Malissen; Elazar Zelzer; Steffen Jung
Journal:  Immunity       Date:  2012-12-27       Impact factor: 31.745

4.  Developmental origin of lung macrophage diversity.

Authors:  Serena Y S Tan; Mark A Krasnow
Journal:  Development       Date:  2016-03-07       Impact factor: 6.868

Review 5.  Monocytes in myocardial infarction.

Authors:  Partha Dutta; Matthias Nahrendorf
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-03-19       Impact factor: 8.311

6.  Lung interstitial macrophages alter dendritic cell functions to prevent airway allergy in mice.

Authors:  Denis Bedoret; Hugues Wallemacq; Thomas Marichal; Christophe Desmet; Florence Quesada Calvo; Emmanuelle Henry; Rodrigue Closset; Benjamin Dewals; Caroline Thielen; Pascal Gustin; Laurence de Leval; Nico Van Rooijen; Alain Le Moine; Alain Vanderplasschen; Didier Cataldo; Pierre-Vincent Drion; Muriel Moser; Pierre Lekeux; Fabrice Bureau
Journal:  J Clin Invest       Date:  2009-11-09       Impact factor: 14.808

7.  Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2.

Authors:  Natalya V Serbina; Eric G Pamer
Journal:  Nat Immunol       Date:  2006-02-05       Impact factor: 25.606

8.  Decreased atherosclerosis in CX3CR1-/- mice reveals a role for fractalkine in atherogenesis.

Authors:  Philippe Lesnik; Christopher A Haskell; Israel F Charo
Journal:  J Clin Invest       Date:  2003-02       Impact factor: 14.808

9.  Defects in macrophage recruitment and host defense in mice lacking the CCR2 chemokine receptor.

Authors:  T Kurihara; G Warr; J Loy; R Bravo
Journal:  J Exp Med       Date:  1997-11-17       Impact factor: 14.307

10.  Distinct bone marrow-derived and tissue-resident macrophage lineages proliferate at key stages during inflammation.

Authors:  Luke C Davies; Marcela Rosas; Stephen J Jenkins; Chia-Te Liao; Martin J Scurr; Frank Brombacher; Donald J Fraser; Judith E Allen; Simon A Jones; Philip R Taylor
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

View more
  43 in total

1.  Meta-analysis of blood genome-wide expression profiling studies in pulmonary arterial hypertension.

Authors:  Jason M Elinoff; Adrien J Mazer; Rongman Cai; Mengyun Lu; Grace Graninger; Bonnie Harper; Gabriela A Ferreyra; Junfeng Sun; Michael A Solomon; Robert L Danner
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2019-10-16       Impact factor: 5.464

2.  Cytokines, Chemokines, and Inflammation in Pulmonary Arterial Hypertension.

Authors:  Shuxin Liang; Ankit A Desai; Stephen M Black; Haiyang Tang
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 3.  The Search for Disease-Modifying Therapies in Pulmonary Hypertension.

Authors:  Chen-Shan Chen Woodcock; Stephen Y Chan
Journal:  J Cardiovasc Pharmacol Ther       Date:  2019-02-17       Impact factor: 2.457

4.  Nonclassical Monocytes Sense Hypoxia, Regulate Pulmonary Vascular Remodeling, and Promote Pulmonary Hypertension.

Authors:  Yen-Rei A Yu; Yuryi Malakhau; Chen-Hsin A Yu; Stefan-Laural J Phelan; R Ian Cumming; Matthew J Kan; Lan Mao; Sudarshan Rajagopal; Claude A Piantadosi; Michael D Gunn
Journal:  J Immunol       Date:  2020-01-29       Impact factor: 5.422

Review 5.  The molecular rationale for therapeutic targeting of glutamine metabolism in pulmonary hypertension.

Authors:  Thomas Bertero; Dror Perk; Stephen Y Chan
Journal:  Expert Opin Ther Targets       Date:  2019-05-11       Impact factor: 6.902

6.  Peripheral blood mononuclear cells show prominent gene expression by erythroid progenitors in diseases characterized by heightened erythropoiesis.

Authors:  Xu Zhang; Jihyun Song; Binal N Shah; Sergei Nekhai; Galina Miasnikova; Adelina Sergueeva; Josef T Prchal; Victor R Gordeuk
Journal:  Br J Haematol       Date:  2020-05-12       Impact factor: 6.998

7.  Interstitial macrophage-derived thrombospondin-1 contributes to hypoxia-induced pulmonary hypertension.

Authors:  Rahul Kumar; Claudia Mickael; Biruk Kassa; Linda Sanders; Daniel Hernandez-Saavedra; Daniel E Koyanagi; Sushil Kumar; Steve C Pugliese; Stacey Thomas; Jazalle McClendon; James P Maloney; William J Janssen; Kurt R Stenmark; Rubin M Tuder; Brian B Graham
Journal:  Cardiovasc Res       Date:  2020-10-01       Impact factor: 10.787

8.  Monocyte and Alveolar Macrophage Skewing Is Associated with the Development of Pulmonary Arterial Hypertension in a Primate Model of HIV Infection.

Authors:  Finja Schweitzer; Rebecca Tarantelli; Emily Rayens; Heather M Kling; Joshua T Mattila; Karen A Norris
Journal:  AIDS Res Hum Retroviruses       Date:  2018-10-30       Impact factor: 2.205

9.  COVID-19 severity associates with pulmonary redistribution of CD1c+ DCs and inflammatory transitional and nonclassical monocytes.

Authors:  Ildefonso Sánchez-Cerrillo; Pedro Landete; Beatriz Aldave; Santiago Sánchez-Alonso; Ana Sánchez-Azofra; Ana Marcos-Jiménez; Elena Ávalos; Ana Alcaraz-Serna; Ignacio de Los Santos; Tamara Mateu-Albero; Laura Esparcia; Celia López-Sanz; Pedro Martínez-Fleta; Ligia Gabrie; Luciana Del Campo Guerola; Hortensia de la Fuente; María J Calzada; Isidoro González-Álvaro; Arantzazu Alfranca; Francisco Sánchez-Madrid; Cecilia Muñoz-Calleja; Joan B Soriano; Julio Ancochea; Enrique Martín-Gayo
Journal:  J Clin Invest       Date:  2020-12-01       Impact factor: 14.808

10.  Single-Cell Study of Two Rat Models of Pulmonary Arterial Hypertension Reveals Connections to Human Pathobiology and Drug Repositioning.

Authors:  Jason Hong; Douglas Arneson; Soban Umar; Gregoire Ruffenach; Christine M Cunningham; In Sook Ahn; Graciel Diamante; May Bhetraratana; John F Park; Emma Said; Caroline Huynh; Trixie Le; Lejla Medzikovic; Marc Humbert; Florent Soubrier; David Montani; Barbara Girerd; David-Alexandre Trégouët; Richard Channick; Rajan Saggar; Mansoureh Eghbali; Xia Yang
Journal:  Am J Respir Crit Care Med       Date:  2021-04-15       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.